Two former executives at a Massachusetts-based manufacturer of blood lead level tests have agreed to plead guilty in connection with the widespread marketing of three tests that allegedly produced inaccurately low blood lead level results for thousands of children and other patients and the concealment of the malfunction from the FDA (United States v. Maleknia, No. No. 1:23-cr... Read More